Notification That Annual Report Will Be Submitted Late (nt 10-k)
March 31 2023 - 8:30AM
Edgar (US Regulatory)
|
|
SEC
FILE NUMBER |
|
|
|
001-35141 |
|
|
|
|
|
|
|
CUSIP
NUMBER |
|
|
|
759757
867 |
|
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐
Form 10-D ☐ Form N-CEN ☐ Form N-CSR
|
|
For
Period Ended: December 31, 2022 |
|
|
|
|
|
☐
Transition Report on Form 10-K |
|
|
|
|
|
☐
Transition Report on Form 20-F |
|
|
|
|
|
☐
Transition Report on Form 11-K |
|
|
|
|
|
☐
Transition Report on Form 10-Q |
|
|
|
|
|
For
the Transition Period Ended: |
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Rennova
Health, Inc.
Full
Name of Registrant
Former
Name if Applicable
400 South Australian Avenue, Suite 800
Address
of Principal Executive Office (Street and Number)
West
Palm Beach, FL 33401
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
|
|
|
|
|
|
|
|
(a)
|
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; |
|
|
|
|
|
☒ |
|
(b)
|
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN
or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D,
or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
|
|
|
|
|
|
|
|
(c)
|
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
Rennova Health, Inc. (the “Company”)
is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the year ended December 31, 2022 within
the prescribed time period because the Company is still compiling information for the Form 10-K and its auditors have not completed their
audit of the financial statements for the year then ended. The Company expects to file its Form 10-K on or prior to the fifteenth calendar
day following the prescribed due date.
Persons
who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.
(Attach
extra Sheets if Needed)
PART
IV — OTHER INFORMATION
(1) |
|
Name
and telephone number of person to contact in regard to this notification |
Seamus
Lagan |
|
561 |
|
855-1626 |
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
|
|
|
|
|
|
|
(2) |
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed? If answer is no, identify report(s). |
|
|
Yes ☒ No ☐ |
|
|
|
(3) |
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof? |
|
|
Yes ☐ No ☒ |
|
|
|
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made. |
Rennova
Health, Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date
|
March
31, 2023
|
|
By |
/s/
Seamus Lagan |
|
|
|
|
Seamus
Lagan |
|
|
|
|
Chief
Executive Officer |
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Rennova Health (CE) (USOTC:RNVA)
Historical Stock Chart
From Aug 2023 to Aug 2024